Capsugel

Capsugel company information, Employees & Contact Information

Explore related pages

Related company profiles:

Follow us on our Lonza Capsules & Health Ingredients LinkedIn page. Lonza's Capsules & Health Ingredients business is the trusted business partner in innovative capsules, dosage form solutions and health ingredients for pharmaceutical and health and nutrition companies. Our reputation for capsule expertise and science-backed ingredients has connected 5,000 global customers, who ultimately enable hundreds of millions of patients and consumers to live a healthier life. CHI has its roots from legacy Lonza ingredients united with two Lonza acquisitions, Capsugel and InterHealth Nutraceuticals.

Company Details

Employees
934
Address
412 Mt. Kemble Ave, Suite 200s,united States
Phone
(864) 942-6610
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Morristown, NJ
Looking for a particular Capsugel employee's phone or email?

Capsugel Questions

News

Lonza Capsugel launches organic, vegan capsule line - SupplySide Supplement Journal

Lonza Capsugel launches organic, vegan capsule line SupplySide Supplement Journal

Lonza Confirms Talks With Capsugel - CHEManager

Lonza Confirms Talks With Capsugel CHEManager

Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe - PR Newswire

Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe PR Newswire

CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals - nutritioninsight.com

CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals nutritioninsight.com

Lonza to buy US capsule maker Capsugel for $5.5 billion - CNBC

Lonza to buy US capsule maker Capsugel for $5.5 billion CNBC

Lonza plots $93M expansion to capsule manufacturing, adding billions of doses per year - Fierce Pharma

Lonza plots $93M expansion to capsule manufacturing, adding billions of doses per year Fierce Pharma

Lonza swallows Capsugel in deal worth $5.5B - BioPharma Dive

Lonza swallows Capsugel in deal worth $5.5B BioPharma Dive

Capsugel Spray-Dried Dispersion Facility, Bend City, Oregon - Pharmaceutical Technology

Capsugel Spray-Dried Dispersion Facility, Bend City, Oregon Pharmaceutical Technology

Capsule oral dosage forms: providing benefits throughout the entire drug product lifecycle - Nutraceutical Business Review

Capsule oral dosage forms: providing benefits throughout the entire drug product lifecycle Nutraceutical Business Review

Lonza will acquire capsule maker Capsugel - Chemical & Engineering News

Lonza will acquire capsule maker Capsugel Chemical & Engineering News

Capsugel's Scintigraphic In Vivo Study of DRcaps™ Capsules Visually Tracks Successful Delayed Release of Ingredients - PRWeb

Capsugel's Scintigraphic In Vivo Study of DRcaps™ Capsules Visually Tracks Successful Delayed Release of Ingredients PRWeb

Lonza Buys Capsugel for $5.5B Cash - Genetic Engineering and Biotechnology News

Lonza Buys Capsugel for $5.5B Cash Genetic Engineering and Biotechnology News

Capsugel Launches Licaps System - SupplySide Supplement Journal

Capsugel Launches Licaps System SupplySide Supplement Journal

Capsugel Expands Late-Stage Inhalation Product Development Capabilities - PR Newswire

Capsugel Expands Late-Stage Inhalation Product Development Capabilities PR Newswire

Lonza says it is negotiating deal to buy Capsugel - Fierce Pharma

Lonza says it is negotiating deal to buy Capsugel Fierce Pharma

Lonza's Capsule Delivery Solutions launches Capsugel Vcaps Gen C - Nutraceutical Business Review

Lonza's Capsule Delivery Solutions launches Capsugel Vcaps Gen C Nutraceutical Business Review

Capsugel subsidiary flagged by Swedish regulator for GMP failures - BioPharma Dive

Capsugel subsidiary flagged by Swedish regulator for GMP failures BioPharma Dive

Capsugel Expands Micro-Dosing Services to Help Accelerate Customers' Product Development Timelines - PR Newswire

Capsugel Expands Micro-Dosing Services to Help Accelerate Customers' Product Development Timelines PR Newswire

Licaps® - SupplySide Supplement Journal

Licaps® SupplySide Supplement Journal

Lonza and Capsugel: A Perfect Match? - SupplySide Supplement Journal

Lonza and Capsugel: A Perfect Match? SupplySide Supplement Journal

Lonza says $5.5B deal for Capsugel gets regulatory approvals - Fierce Pharma

Lonza says $5.5B deal for Capsugel gets regulatory approvals Fierce Pharma

Lonza to buy U.S. drug capsule maker Capsugel from KKR for $5.5 billion - Reuters

Lonza to buy U.S. drug capsule maker Capsugel from KKR for $5.5 billion Reuters

Lonza forecasts $7.9B in annual revenues by 2022, helped by Capsugel buy - Fierce Pharma

Lonza forecasts $7.9B in annual revenues by 2022, helped by Capsugel buy Fierce Pharma

Capsugel Finds Its Hard Gelatin Capsules to be QbD-Ready - Contract Pharma

Capsugel Finds Its Hard Gelatin Capsules to be QbD-Ready Contract Pharma

Lonza to acquire Capsugel - New Hope Network

Lonza to acquire Capsugel New Hope Network

Capsugel scores Vegan cert for 4 capsules - New Hope Network

Capsugel scores Vegan cert for 4 capsules New Hope Network

Capsugel to acquire Bend Research - European Pharmaceutical Review

Capsugel to acquire Bend Research European Pharmaceutical Review

Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers - ScienceDirect.com

Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers ScienceDirect.com

Capsugel ~ DRcaps - SupplySide Supplement Journal

Capsugel ~ DRcaps SupplySide Supplement Journal

EMA pulls GMP certificate for U.S. facility - Fierce Pharma

EMA pulls GMP certificate for U.S. facility Fierce Pharma

Blackstone, Bain Reportedly Exploring Bid For Pfizer's Capsugel Unit - Update - RTTNews

Blackstone, Bain Reportedly Exploring Bid For Pfizer's Capsugel Unit - Update RTTNews

Lonza Group AG to buy Capsugel from KKR & Co for $5.5bn - Financier Worldwide

Lonza Group AG to buy Capsugel from KKR & Co for $5.5bn Financier Worldwide

Capsugel/Lonza Exports Capsules From New Jersey To Cuba; On Behalf Of Customer In Europe - U.S. - Cuba Trade and Economic Council, Inc.

Capsugel/Lonza Exports Capsules From New Jersey To Cuba; On Behalf Of Customer In Europe U.S. - Cuba Trade and Economic Council, Inc.

Fabrication of delayed release hard capsule shells from zein/methacrylic acid copolymer blends - ScienceDirect.com

Fabrication of delayed release hard capsule shells from zein/methacrylic acid copolymer blends ScienceDirect.com

Lonza Adds More Building Blocks for the Healthcare Continuum - CHEManager

Lonza Adds More Building Blocks for the Healthcare Continuum CHEManager

Capsugel said to explore sale, IPO - MassDevice

Capsugel said to explore sale, IPO MassDevice

Capsugel completes $25M spray-dried expansion - Fierce Pharma

Capsugel completes $25M spray-dried expansion Fierce Pharma

Capsugel - Manufacturing Today

Capsugel Manufacturing Today

Lonza expands Capsugel range with TiO2-free white hard gelatine capsules - NutraIngredients.com

Lonza expands Capsugel range with TiO2-free white hard gelatine capsules NutraIngredients.com

Capsugel: Capsules secure containment of liquids and semi-solids - Healthcare Packaging

Capsugel: Capsules secure containment of liquids and semi-solids Healthcare Packaging

ECM loses Capsugel IPO but gets Sfr3bn Lonza rights issue - GlobalCapital

ECM loses Capsugel IPO but gets Sfr3bn Lonza rights issue GlobalCapital

Advancements in Encapsulation Technology - PharmTech

Advancements in Encapsulation Technology PharmTech

Lonza buys gelatin capsules maker Capsugel from KKR for $ 5.5 billion - Business Standard

Lonza buys gelatin capsules maker Capsugel from KKR for $ 5.5 billion Business Standard

Would Lonza’s Acquisition of Capsugel be Opportunity for Samsung Biologics? - Businesskorea

Would Lonza’s Acquisition of Capsugel be Opportunity for Samsung Biologics? Businesskorea

Lonza in talks to buy Capsugel for $5 bn - Oman Observer

Lonza in talks to buy Capsugel for $5 bn Oman Observer

Top Capsugel Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant